Maurya, S. Et Al. 2022. In-silico study reveals potential antitubercular drug targets unique to Mycobacterium tuberculosis H37Rv. MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH , vol.34, no.2 , 71-79.

Maurya, S., Alhazmi, A., Vidyarthi, A. S., Jain, A., Singh, V., Khan, F., ... Haque, S.(2022). In-silico study reveals potential antitubercular drug targets unique to Mycobacterium tuberculosis H37Rv. MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH , vol.34, no.2, 71-79.

Maurya, Satyamvada Et Al. "In-silico study reveals potential antitubercular drug targets unique to Mycobacterium tuberculosis H37Rv," MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH , vol.34, no.2, 71-79, 2022

Maurya, Satyamvada Et Al. "In-silico study reveals potential antitubercular drug targets unique to Mycobacterium tuberculosis H37Rv." MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH , vol.34, no.2, pp.71-79, 2022

Maurya, S. Et Al. (2022) . "In-silico study reveals potential antitubercular drug targets unique to Mycobacterium tuberculosis H37Rv." MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH , vol.34, no.2, pp.71-79.

@article{article, author={Satyamvada Maurya Et Al. }, title={In-silico study reveals potential antitubercular drug targets unique to Mycobacterium tuberculosis H37Rv}, journal={MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH}, year=2022, pages={71-79} }